Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 2 |
Costco
COST
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$270M |
| 4 |
Pfizer
PFE
|
+$240M |
| 5 |
Microsoft
MSFT
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$274M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL Resources Inc
GAS
|
+$216M |
| 4 |
TE
TECO ENERGY INC
TE
|
+$136M |
| 5 |
Charter Communications
CHTR
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.75% |
| 2 | Healthcare | 13.12% |
| 3 | Financials | 12.46% |
| 4 | Consumer Staples | 9.7% |
| 5 | Industrials | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Brunswick
BC
$5.36B
| $3.67M | 0.01% |
75,300
+7,100
| +10% | +$339K |
|
|
PTLA
1802
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $3.67M | 0.01% |
161,500
-187,900
| -54% | -$4.41M |
|
|
EXA
1803
DELISTED
EXA Corporation
EXA
| $3.66M | 0.01% |
228,000
+46,400
| +26% | +$698K |
|
|
FBNK
1804
DELISTED
First Connecticut Bancorp, Inc
FBNK
| $3.66M | 0.01% |
205,500
+8,600
| +4% | +$146K |
|
1805
Churchill Downs
CHDN
$6.33B
| $3.65M | 0.01% |
149,850
-400,800
| -73% | -$9.44M |
|
|
KE
1806
Kimball Electronics
KE
$622M
| $3.65M | 0.01% |
263,675
+15,600
| +6% | +$194K |
|
|
AVHI
1807
DELISTED
A V Homes, Inc.
AVHI
| $3.65M | 0.01% |
219,400
+35,000
| +19% | +$503K |
|
|
CRAY
1808
DELISTED
Cray, Inc.
CRAY
| $3.65M | 0.01% |
154,951
-35,000
| -18% | -$893K |
|
1809
Clearwater Paper
CLW
$345M
| $3.65M | 0.01% |
56,400
+18,200
| +48% | +$1.15M |
|
1810
Seres Therapeutics
MCRB
$45.6M
| $3.64M | 0.01% |
+14,825
| New | +$5.2M |
|
1811
LeMaitre Vascular
LMAT
$1.88B
| $3.64M | 0.01% |
183,500
+84,200
| +85% | +$1.47M |
|
1812
Corcept Therapeutics
CORT
$12.4B
| $3.64M | 0.01% |
560,000
+249,400
| +80% | +$1.45M |
|
|
CLUB
1813
DELISTED
Town Sports International Holdings, Inc.
CLUB
| $3.64M | 0.01% |
1,177,941
+47,441
| +4% | +$132K |
|
1814
Suburban Propane Partners
SPH
$1.18B
| $3.63M | 0.01% |
109,167
-96,200
| -47% | -$3.24M |
|
1815
James River Group Holdings
JRVR
$193M
| $3.63M | 0.01% |
100,400
-10,900
| -10% | -$383K |
|
1816
Silicon Laboratories
SLAB
$7.29B
| $3.63M | 0.01% |
61,800
-29,498
| -32% | -$1.59M |
|
1817
Evolent Health
EVH
$529M
| $3.62M | 0.01% |
+146,900
| New | +$3.43M |
|
1818
RBC Bearings
RBC
$17.7B
| $3.6M | 0.01% |
47,000
+17,500
| +59% | +$1.34M |
|
|
TUP
1819
DELISTED
Tupperware Brands Corporation
TUP
| $3.59M | 0.01% |
+54,900
| New | +$3.45M |
|
1820
NiSource
NI
$20.4B
| $3.58M | 0.01% |
+148,400
| New | +$3.71M |
|
|
FGH
1821
DELISTED
FG Group Holdings Inc.
FGH
| $3.58M | 0.01% |
510,900
+37,405
| +8% | +$215K |
|
|
GCAP
1822
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $3.57M | 0.01% |
577,600
+94,900
| +20% | +$618K |
|
1823
Superior Group of Companies
SGC
$208M
| $3.56M | 0.01% |
180,100
-15,000
| -8% | -$269K |
|
|
ARQL
1824
DELISTED
Arqule Inc
ARQL
| $3.56M | 0.01% |
1,990,700
-37,883
| -2% | -$60.1K |
|
1825
Home Bancorp
HBCP
$566M
| $3.56M | 0.01% |
127,214
-13,172
| -9% | -$374K |
|
Similar funds
Jim Simons's Q3 2016 Portfolio in Review
As of Q3 2016, Jim Simons held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $1.92B of net new capital in Q3 2016, opening 414 new positions and adding to 1,834 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.
- Jim Simons's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
- Jim Simons added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
- Jim Simons's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
- Jim Simons fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
- Jim Simons's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
- Jim Simons opened 414 new positions and closed 416 in Q3 2016.
- Jim Simons's portfolio value rose 7.7% quarter-over-quarter to $56.6B.
Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.